Skip to main content
Erschienen in: Supportive Care in Cancer 11/2018

03.06.2018 | Commentary

Prehabilitation for surgical oncology patients: empowering patient volition

verfasst von: Rahul Jain, Leslie Gibson, Natalie Coburn

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Prehabilitation is the improvement of patient health in anticipation of a physiological stressor, such as major surgery. Prehabilitation optimizes health by taking a proactive approach to promoting exercise, nutrition, and lifestyle modifications. Engaging patients in the pre-operative phase provides an opportunity to positively impact their recovery and return to functional baseline by reducing post-operative deconditioning. At the Odette Cancer Centre at Sunnybrook Health Sciences Centre in Toronto, Canada, the Interprofessional Multidisciplinary Prehabilitation Assessment Consultation Team (IMPACT—Surgical Oncology) was developed. The program was initiated in January 2015 and assesses approximately 3–5 patients/week (with a total of over 250 patients so far). This program offers patients individualized pre-operative assessments, including medical optimization, functional, and nutritional assessments, as well as counseling for mood-related issues, smoking/alcohol cessation, and preparing for surgery (such as ensuring adequate home supports/functional equipment prior to surgery). By providing holistic, person-centered, individualized pre-operative optimization strategies, patients and families feel empowered, motivated, and in control of their own health.
Literatur
1.
Zurück zum Zitat Carli F, Charlebois P, Stein B, Feldman L, Zavorsky G, Kim DJ, Scott S, Mayo NE (2010) Randomized clinical trial of prehabilitation in colorectal surgery. Br J Surg 97:1187–1197CrossRef Carli F, Charlebois P, Stein B, Feldman L, Zavorsky G, Kim DJ, Scott S, Mayo NE (2010) Randomized clinical trial of prehabilitation in colorectal surgery. Br J Surg 97:1187–1197CrossRef
2.
Zurück zum Zitat West MA, Loughney L, Lythgoe D, Barben CP, Sripadam R, Kemp GJ, Grocott MP, Jack S (2015) Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. Br J Anesth 114:224–251 West MA, Loughney L, Lythgoe D, Barben CP, Sripadam R, Kemp GJ, Grocott MP, Jack S (2015) Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. Br J Anesth 114:224–251
3.
Zurück zum Zitat Carli F, Scheede-Bergdahl C (2015) Prehabilitation to enhance perioperative care. Anesthiol Clin 33:17–33CrossRef Carli F, Scheede-Bergdahl C (2015) Prehabilitation to enhance perioperative care. Anesthiol Clin 33:17–33CrossRef
4.
Zurück zum Zitat Swank AM, Kachelman JB, Bibeau W, Quesada PM, Nyland J, Malkani A, Topp RV (2011) Prehabilitation before total knee arthroplasty increases strength and function in older adults with severe osteoarthritis. J Strength Cond Res 25:318–325CrossRef Swank AM, Kachelman JB, Bibeau W, Quesada PM, Nyland J, Malkani A, Topp RV (2011) Prehabilitation before total knee arthroplasty increases strength and function in older adults with severe osteoarthritis. J Strength Cond Res 25:318–325CrossRef
5.
Zurück zum Zitat Allen JK, Becker DM, Swank RT (1990) Factors related to functional status after coronary artery bypass surgery. Heart Lung 19:337–343PubMed Allen JK, Becker DM, Swank RT (1990) Factors related to functional status after coronary artery bypass surgery. Heart Lung 19:337–343PubMed
6.
Zurück zum Zitat Carli F, Gillis C, Scheede-Bergdahl C (2017) Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol 56:128–133CrossRef Carli F, Gillis C, Scheede-Bergdahl C (2017) Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol 56:128–133CrossRef
7.
Zurück zum Zitat Carli F, Zavorsky GS (2005) Optimizing functional exercise capacity in the elderly surgical population. Curr Opin Clin Nutr Metab Care 8:23–32CrossRef Carli F, Zavorsky GS (2005) Optimizing functional exercise capacity in the elderly surgical population. Curr Opin Clin Nutr Metab Care 8:23–32CrossRef
8.
Zurück zum Zitat Green EC, Murphy E (2014) Health Belief Model. In: Cockerham WC, Dingwall R, Quah SR (eds) The Wiley Blackwell encyclopedia of health, illness, behavior, and society. Wiley-Blackwell, Massachusetts, pp 766–769CrossRef Green EC, Murphy E (2014) Health Belief Model. In: Cockerham WC, Dingwall R, Quah SR (eds) The Wiley Blackwell encyclopedia of health, illness, behavior, and society. Wiley-Blackwell, Massachusetts, pp 766–769CrossRef
9.
Zurück zum Zitat Brédart A, Bouleuc C, Dolbeault S (2005) Doctor-patient communication and satisfaction with care in oncology. Curr Opin Oncol 17:351–354CrossRef Brédart A, Bouleuc C, Dolbeault S (2005) Doctor-patient communication and satisfaction with care in oncology. Curr Opin Oncol 17:351–354CrossRef
10.
Zurück zum Zitat Guadagnoli E, Ward P (1998) Patient participation in decision-making. Soc Sci Med 47:329–339CrossRef Guadagnoli E, Ward P (1998) Patient participation in decision-making. Soc Sci Med 47:329–339CrossRef
Metadaten
Titel
Prehabilitation for surgical oncology patients: empowering patient volition
verfasst von
Rahul Jain
Leslie Gibson
Natalie Coburn
Publikationsdatum
03.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4300-4

Weitere Artikel der Ausgabe 11/2018

Supportive Care in Cancer 11/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.